subject
complet
health
statu
questionnair
provid
blood
sampl
serolog
test
result
total
worker
particip
posit
serolog
hospit
area
individu
posit
serolog
emerg
depart
profession
categori
individu
posit
serolog
work
orderli
conclus
around
healthcar
worker
hospit
posit
serolog
peak
pandem
none
receiv
vaccin
influenza
diagnos
influenza
previous
elsevi
sl
right
reserv
lo
trabajador
completaron
un
cuestionario
de
salud
la
par
que
se
le
una
muestra
de
sangr
para
la
april
first
case
among
human
influenza
viru
confirm
mexico
usa
june
pandem
situat
declar
world
health
organis
outset
case
nosocomi
transmiss
confirm
affect
healthcar
staff
moreov
previou
experi
sever
acut
respiratori
syndrom
sar
se
asia
led
research
believ
healthcar
worker
would
particularli
vulner
appear
new
viru
howev
first
seri
publish
show
healthcar
worker
overrepres
incid
symptomat
case
hypothesis
result
greater
exposur
viru
work
acquir
higher
immun
present
gener
popul
date
studi
made
seropreval
among
healthcar
worker
result
report
contradictori
present
studi
propos
determin
seropreval
antibodi
influenza
viru
pandem
among
popul
healthcar
worker
hypothesis
exposur
viru
vari
accord
area
work
within
hospit
accord
profession
categori
worker
follow
gradient
greater
lesser
exposur
depend
area
hospit
question
emerg
medic
area
surgic
area
transvers
studi
carri
hospit
costa
del
sol
marbella
spain
hospit
around
bed
serv
refer
popul
person
accord
data
spanish
nation
statist
institut
januari
particip
studi
propos
discuss
perman
staff
emerg
intern
medicin
pneumolog
depart
medic
area
gener
surgeri
anaesthesia
surgic
area
collabor
provid
emerg
staff
high
resolut
specialist
centr
hare
associ
hospit
latter
centr
emerg
case
attend
shortterm
bed
exceed
h
avail
accord
profession
categori
particip
personnel
divid
doctor
nurs
nurs
auxiliari
staff
orderli
administr
staff
particip
gave
written
sign
consent
complet
questionnair
presenc
otherwis
influenzarel
symptom
comorbid
associ
poor
prognosi
influenza
also
includ
question
subject
state
season
pandem
influenza
vaccin
case
influenza
immedi
famili
daili
handwash
work
home
pharmacolog
treatment
taken
influenza
diagnosi
season
influenza
influenza
infect
latter
confirm
pcrposit
nasal
swab
main
studi
variabl
presenc
titr
new
influenza
viru
sampl
kept
cold
storag
hospit
sent
nation
microbiolog
centr
majadahonda
madrid
spain
analys
detect
antibodi
influenza
viru
respons
pandem
analysi
perform
use
haemagglutin
inhibit
techniqu
modif
method
previous
describ
antibodi
titr
serum
greatest
dilut
present
inhibit
haemagglutin
power
viral
antigen
sera
consid
posit
titr
equal
greater
descript
analysi
perform
measur
central
tendenc
dispers
continu
variabl
frequenc
distribut
qualit
one
bivari
analysi
principl
variabl
presenc
absenc
iha
subgroup
continu
variabl
compar
mean
mannwhitney
u
test
categor
variabl
compar
use
chi
squar
test
fisher
exact
test
necessari
qualit
one
iha
result
variabl
construct
forward
select
multipl
logist
regress
model
includ
variabl
bivari
analysi
obtain
p
entri
criterion
output
criterion
includ
odd
ratio
valu
confid
interv
ci
level
statist
signific
establish
p
total
healthcar
worker
particip
studi
work
emerg
depart
medic
area
surgic
area
emerg
depart
peripher
centr
associ
hospit
princip
characterist
particip
summaris
tabl
includ
symptom
report
moment
blood
sampl
taken
none
particip
report
suffer
dyspnea
none
worker
diagnos
influenza
vaccin
viru
howev
worker
diagnos
season
influenza
vaccin
season
influenza
one
worker
take
medic
oseltamivir
particip
present
antibodi
titr
determin
iha
geometr
mean
valu
proport
posit
result
significantli
differ
among
divers
hospit
depart
emerg
depart
medic
area
surgic
area
peripher
centr
associ
hospit
p
also
observ
differ
profession
categori
posit
result
among
doctor
nurs
nurs
auxiliari
staff
administr
staff
orderli
p
posit
serolog
record
among
women
vs
men
femal
vs
male
p
differ
averag
age
seroposit
seroneg
subject
none
comorbid
associ
greater
preval
posit
serolog
respect
symptom
presenc
rhinorrhoea
day
serolog
determin
significantli
associ
greater
proport
seroposit
subject
vs
p
differ
respect
influenza
diagnos
among
famili
member
whether
vaccin
season
influenza
receiv
worker
diagnos
season
influenza
present
posit
serolog
vs
subject
p
geometr
mean
antibodi
level
patient
higher
diagnos
season
influenza
although
without
reach
statist
signific
vs
p
initi
logist
regress
analysi
perform
outcom
variabl
present
posit
serolog
iha
independ
variabl
gender
age
hospit
area
worker
activ
profession
categori
presenc
rhinorrhoea
prior
diagnosi
season
influenza
factor
subsequ
maintain
model
femal
gender
ci
rhinorrhoea
ci
prior
diagnosi
influenza
ci
well
profession
categori
orderli
administr
staff
doctor
tabl
summaris
result
logist
regress
analysi
second
model
construct
exclud
worker
previous
diagnos
season
influenza
result
shown
tabl
model
factor
subsequ
maintain
rhinorrhoea
ci
work
emerg
area
ci
profession
categori
doctor
administr
staff
orderli
respect
seri
observ
high
preval
healthcar
worker
present
posit
serolog
influenza
viru
respons
pandem
quarter
studi
subject
affect
furthermor
higher
preval
emerg
depart
area
exposur
respiratori
virus
assum
greater
aggrav
constant
flow
patient
sever
banal
patholog
exposur
viru
could
gradual
time
studi
carri
week
epidemiolog
year
although
pandem
declar
week
penetr
influenza
viru
moment
rel
low
reach
threshold
valu
previou
year
week
onward
pandem
viru
predomin
throughout
spain
worker
previous
diagnos
season
influenza
high
probabl
present
nonsever
influenza
threshold
valu
exceed
week
rise
phase
pandem
wave
verifi
spain
week
data
predat
moment
greatest
expans
viru
studi
popul
rel
young
absenc
influenza
symptom
present
humor
immun
level
measur
iha
compar
gener
popul
follow
first
spike
pandem
unit
kingdom
studi
miller
et
al
popul
group
age
year
present
preval
rate
posit
serolog
ci
although
observ
first
spike
tabl
result
logist
regress
analysi
exclud
subject
prior
diagnosi
season
influenza
odd
ratio
ci
p
incid
influenza
viru
occur
prior
extract
sampl
studi
expans
viru
spain
even
enter
rise
phase
pandem
wave
support
hypothesi
least
among
healthcar
worker
humor
immun
acquir
probabl
result
repeat
exposur
viru
volunt
particip
studi
mean
age
year
exclud
possibl
humor
immun
acquir
could
relat
histor
exposur
influenza
viru
case
born
also
reject
hypothesi
immun
relat
prior
vaccin
season
influenza
viru
crossreact
pandem
viru
almost
nonexist
high
seropreval
observ
coher
fact
healthcar
worker
present
higher
incid
case
influenza
despit
presum
greater
exposur
result
work
although
expos
proport
protect
subject
would
also
higher
noteworthi
rhinorrhoea
significantli
associ
posit
serolog
probabl
express
banal
respiratori
disord
could
includ
infect
caus
influenza
viru
case
prior
diagnosi
season
influenza
probabl
oligosymptomat
influenza
exclud
analysi
profession
categori
popul
present
highest
risk
seroposit
doctor
follow
orderli
administr
staff
although
case
doctor
could
explain
high
rate
exposur
symptomat
case
would
case
administr
staff
latter
case
might
reflect
exposur
deriv
simpli
presenc
hospit
without
adopt
special
measur
protect
studi
particip
select
random
sampl
recruit
volunt
therefor
select
bia
might
present
moreov
calcul
sampl
size
beforehand
limit
power
conclus
although
moment
design
studi
prior
inform
seropreval
among
healthcar
worker
main
goal
compil
inform
pandem
reach
peak
date
two
seri
serolog
studi
publish
regard
healthcar
worker
influenza
pandem
one
studi
describ
seropreval
context
pandem
wave
taiwan
identifi
seroposit
rate
among
healthcar
worker
vs
gener
popul
also
seen
higher
proport
seroposit
result
among
worker
face
highest
risk
emerg
infecti
diseas
depart
vs
low
risk
find
similar
obtain
seri
although
case
differ
accord
area
work
within
hospit
clearcut
second
studi
concern
incid
seroconvers
among
popul
healthcar
worker
singapor
studi
report
seroconvers
associ
significantli
episod
respiratori
infect
work
nurs
work
area
influenza
patient
hospitalis
find
suggest
exposur
workplac
associ
higher
rate
seroconvers
studi
carri
rise
phrase
pandem
wave
region
studi
reveal
high
degre
immunis
among
healthcar
worker
rise
pandem
wave
spain
type
studi
popul
high
risk
exposur
help
contextualis
expans
emerg
virus
influenza
viru
respons
pandem
project
fund
instituto
de
salud
carlo
iii
ciber
de
salud
